People: Cempra Inc (CEMP.O)

CEMP.O on Nasdaq

13.63USD
21 Nov 2014
Price Change (% chg)

$0.20 (+1.49%)
Prev Close
$13.43
Open
$13.73
Day's High
$13.87
Day's Low
$13.56
Volume
179,068
Avg. Vol
280,820
52-wk High
$15.39
52-wk Low
$8.10

Search Stocks

Moore, David 

Brief Biography

Mr. David S. Moore is the Executive Vice President, Chief Commercial Officer of Cempra, Inc. Mr. Moore has spent over 15 years developing and managing pharmaceutical commercial programs, with the majority of those years spent with the Ortho-McNeil and Janssen Pharmaceutical divisions within Johnson & Johnson. Mr. Moore has held leadership roles in key sales and marketing functions, and was part of teams that developed and executed launch plans for several prescription pharmaceuticals for both primary and acute care settings. He was also responsible for developing payer value platforms for several therapeutic areas including antibiotics, pain and women's health, in which he successfully implemented pricing and reimbursement strategies with hospitals and managed care organizations. Following his tenure at Johnson & Johnson, he was chief business officer and vice president of Worldwide Commercial Operations of Tranzyme, Inc., where he was responsible for building the commercial organization as well as in- and out-licensing clinical-stage assets. Before joining Cempra, he was the chief business officer of Ocera Therapeutics where he was responsible for developing the commercial plans for an Orphan-designated advanced liver disease product for both the community and acute care markets. Mr. Moore received his B.Sc. in Biology from Towson University and an M.B.A. from Lehigh University, and a second graduate degree in Health Policy Excellence from Thomas Jefferson University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks